<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Reason For Referral</a></li><li><a href="#id3">REASON FOR VISIT</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Social History</a></li><li><a href="#id6">Problems</a></li><li><a href="#id7">Vital Signs</a></li><li><a href="#id8">Encounters</a></li><li><a href="#id9">Assessments</a></li><li><a href="#id10">Plan Of Treatment</a></li><li><a href="#id11">Progress Notes</a></li><li><a href="#id12">History and Physical Notes</a></li><li><a href="#id13">Consultation Request Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>New patient</td></tr><tr><th>Diagnosis 1</th><td>BPH (BENIGN PROSTATIC HYPERPLASIA) (N40.0)</td></tr><tr><th>Referral Organization</th><td>MCM Tampa [REDACTED] Ave</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Internal Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Urology</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table></div><h3><a name="id3" href="#toc">REASON FOR VISIT</a></h3><div>EOV with labs</div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Neomycin-Polymyxin-HC 1 %</td><td ID="instruction1">4 drops into affected ear Otic every 8 hrs as needed for 7 days</td><td/><td>[REDACTED]</td><td/><td>Not-Taking</td></tr><tr><td ID="medication2">Levothyroxine Sodium 50 MCG</td><td ID="instruction2">1 tablet in the morning on an empty stomach Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Tamsulosin HCl</td><td ID="instruction3">1 capsule Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Famotidine 40 MG</td><td ID="instruction4">TAKE 1 TABLET ONE TIME DAILY AT BEDTIME AS NEEDED for 90</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication5">Tadalafil 2.5 MG</td><td ID="instruction5">1 tablet Orally Once a day for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication6">Meloxicam 15 MG</td><td ID="instruction6">1 tablet Orally Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">oxyCODONE HCl 15 MG</td><td ID="instruction7">1 capsule as needed Orally Q6hrs PRN</td><td ID="medication7notes">PM</td><td/><td/><td>Active</td></tr><tr><td ID="medication8">Famotidine 20 MG</td><td ID="instruction8">1 tablet at bedtime as needed Orally Twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Famotidine 20 MG</td><td ID="instruction9">TAKE 1 TABLET TWICE DAILY for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Diclofenac Sodium 3 %</td><td ID="instruction10">1 application 1-2 grams Externally Twice a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Atorvastatin Calcium 20 MG</td><td ID="instruction11">1 tablet Orally Once a Night for 90 days</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Social History</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>204888000</td><td ID="Problem1">PENILE HYPOSPADIAS (Q54.1)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id7" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>97.2 degrees Fahrenheit</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td>113 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>68 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Heart Rate</th><td>48 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Respiratory Rate</th><td>16 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital6">Height</th><td>71 in</td><td>[REDACTED]</td></tr><tr><th ID="vital7">Weight</th><td>212 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital8">BMI</th><td>29.56 kg/m2</td><td>[REDACTED]</td></tr><tr><th ID="vital9">Oximetry</th><td>96 %</td><td>[REDACTED]</td></tr><tr><th ID="vital10">Height-cm</th><td>180.34 cm</td><td>[REDACTED]</td></tr><tr><th ID="vital11">Weight-kg</th><td>96.16 kg</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Tampa [REDACTED] Ave</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>Jobse [REDACTED]</td><td>Mixed hyperlipidemia E78.2 ; Acquired hypothyroidism E03.9 ; Other osteoarthritis involving multiple joints M15.8 ; Gastroesophageal reflux disease without esophagitis K21.9 ; Anxiety F41.9 ; Low testosterone in male R79.89 ; Other chronic pain G89.29 ; Hesitancy of micturition R39.11 ; Drug-induced erectile dysfunction N52.2 ; Opioid dependence in controlled environment F11.20 ; Sleep apnea, unspecified G47.30 ; Hiatal hernia K44.9 ; Opioid use, unspecified with opioid-induced sexual dysfunction F11.981 ; Seasonal allergies J30.2 ; Hepatic cyst K76.89 ; BPH (BENIGN PROSTATIC HYPERPLASIA) N40.0 ; BMI 31.0-31.9,adult Z68.31 and PENILE HYPOSPADIAS Q54.1</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td>Continue current therapy, low fat diet</td><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Acquired hypothyroidism (ICD-10 - E03.9)</td><td/><td>Continue current treatment</td><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Other osteoarthritis involving multiple joints (ICD-10 - M15.8)</td><td/><td>Continue current treatment</td><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Gastroesophageal reflux disease without esophagitis (ICD-10 - K21.9)</td><td/><td>Avoid irritant foods</td><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Anxiety (ICD-10 - F41.9)</td><td/><td>Continue current treatment</td><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Low testosterone in male (ICD-10 - R79.89)</td><td/><td>Lab reviewed with pt; refused Rx Tx</td><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Other chronic pain (ICD-10 - G89.29)</td><td/><td>PRN TYLENOL for Pain</td><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Hesitancy of micturition (ICD-10 - R39.11)</td><td/><td>monitor for changes</td><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Drug-induced erectile dysfunction (ICD-10 - N52.2)</td><td/><td>take medication as indicated by Urologist</td><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Opioid dependence in controlled environment (ICD-10 - F11.20)</td><td/><td><p/><p>Patient was informed of non-opioid alternatives</p><p>that are available, which may include non-opioid medicinal drugs,</p><p>interventional procedures, acupuncture, chiropractic treatment, massage therapy</p><p>or other appropriate treatment.</p></td><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Sleep apnea, unspecified (ICD-10 - G47.30)</td><td/><td>monitor for changes</td><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Hiatal hernia (ICD-10 - K44.9)</td><td>Bayarea Advance Gastroeneterology Care [REDACTED] notes dated [REDACTED]</td><td>monitor for changes</td><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>Opioid use, unspecified with opioid-induced sexual dysfunction (ICD-10 - F11.981)</td><td/><td><p>1) Drug has been taken for lager amount or over longer period than was intended </p><p>2) Persistent desire or unsuccessful efforts to cut down or control use </p><p>3) Craving or strong desire or urge to use the drug </p><p>4) continued use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely caused or exacerbated by the drug.</p></td><td/></tr><tr><td ID="ref14">[REDACTED]</td><td>Seasonal allergies (ICD-10 - J30.2)</td><td/><td>- Stable, will keep monitoring</td><td/></tr><tr><td ID="ref15">[REDACTED]</td><td>Hepatic cyst (ICD-10 - K76.89)</td><td/><td>- Stable, will keep monitoring</td><td/></tr><tr><td ID="ref16">[REDACTED]</td><td>BPH (BENIGN PROSTATIC HYPERPLASIA) (ICD-10 - N40.0)</td><td/><td>- Stable, will keep monitoring</td><td/></tr><tr><td ID="ref17">[REDACTED]</td><td>BMI 31.0-31.9,adult (ICD-10 - Z68.31)</td><td/><td>Discussed diet modifications and increase in physical activity to obtain or maintain goal BMI</td><td/></tr><tr><td ID="ref18">[REDACTED]</td><td>PENILE HYPOSPADIAS (ICD-10 - Q54.1)</td><td/><td>Urology follow up</td><td/></tr></tbody></table></div><h3><a name="id10" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Levothyroxine Sodium 50 MCG</td><td>1 tablet in the morning on an empty stomach Orally Once a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds2">Meloxicam 15 MG</td><td>1 tablet Orally Twice a day</td><td/><td/><td/></tr><tr><td ID="potMeds3">oxyCODONE HCl 15 MG</td><td>1 capsule as needed Orally Q6hrs PRN</td><td/><td/><td>PM</td></tr><tr><td ID="potMeds4">Famotidine 20 MG</td><td>1 tablet at bedtime as needed Orally Twice a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds5">Diclofenac Sodium 3 %</td><td>1 application 1-2 grams Externally Twice a day for 30 days</td><td/><td/><td/></tr><tr><td ID="potMeds6">Atorvastatin Calcium 20 MG</td><td>1 tablet Orally Once a Night for 90 days</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Mixed hyperlipidemia</td><td>Continue current therapy, low fat diet</td></tr><tr><td ID="instructionpot2">Acquired hypothyroidism</td><td>Continue current treatment</td></tr><tr><td ID="instructionpot3">Other osteoarthritis involving multiple joints</td><td>Continue current treatment</td></tr><tr><td ID="instructionpot4">Gastroesophageal reflux disease without esophagitis</td><td>Avoid irritant foods</td></tr><tr><td ID="instructionpot5">Anxiety</td><td>Continue current treatment</td></tr><tr><td ID="instructionpot6">Low testosterone in male</td><td>Lab reviewed with pt; refused Rx Tx</td></tr><tr><td ID="instructionpot7">Other chronic pain</td><td>PRN TYLENOL for Pain</td></tr><tr><td ID="instructionpot8">Hesitancy of micturition</td><td>monitor for changes</td></tr><tr><td ID="instructionpot9">Drug-induced erectile dysfunction</td><td>take medication as indicated by Urologist</td></tr><tr><td ID="instructionpot10">Opioid dependence in controlled environment</td><td><p/><p>Patient was informed of non-opioid alternatives</p><p>that are available, which may include non-opioid medicinal drugs,</p><p>interventional procedures, acupuncture, chiropractic treatment, massage therapy</p><p>or other appropriate treatment.</p></td></tr><tr><td ID="instructionpot11">Sleep apnea, unspecified</td><td>monitor for changes</td></tr><tr><td ID="instructionpot12">Hiatal hernia</td><td>monitor for changes</td></tr><tr><td ID="instructionpot13">Opioid use, unspecified with opioid-induced sexual dysfunction</td><td><p>1) Drug has been taken for lager amount or over longer period than was intended </p><p>2) Persistent desire or unsuccessful efforts to cut down or control use </p><p>3) Craving or strong desire or urge to use the drug </p><p>4) continued use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely caused or exacerbated by the drug.</p></td></tr><tr><td ID="instructionpot14">Seasonal allergies</td><td>- Stable, will keep monitoring</td></tr><tr><td ID="instructionpot15">Hepatic cyst</td><td>- Stable, will keep monitoring</td></tr><tr><td ID="instructionpot16">BPH (BENIGN PROSTATIC HYPERPLASIA)</td><td>- Stable, will keep monitoring</td></tr><tr><td ID="instructionpot17">BMI 31.0-31.9,adult</td><td>Discussed diet modifications and increase in physical activity to obtain or maintain goal BMI</td></tr><tr><td ID="instructionpot18">PENILE HYPOSPADIAS</td><td>Urology follow up</td></tr></tbody></table><span class="content_span">Referrals</span><table width="100%" border="1"><thead><tr><th>Referral Date</th><th>Details</th></tr></thead><tbody><tr><td ID="referral1">[REDACTED]</td><td>[REDACTED], New patient, [REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 3 Months,on Regular Scheduled OV, Reason: Follow-up of chronic conditions</td></tr><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 09:00:00 AM, [REDACTED][REDACTED][REDACTED], [REDACTED]</td></tr><tr><td ID="futureAppt2">Provider Name:[REDACTED], [REDACTED] 08:30:00 AM, [REDACTED][REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] M) <span class="bold">Acc No.</span> 251373 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>251373</td><td align="right"><span class="bold">Provider: </span>Jobse [REDACTED], MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>66 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   EOV with labs</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">[REDACTED]</span>: <br/>      Patient is here for Patient came in to the office [REDACTED] for EOV for labs and echo results with monitoring; <br/>Hyperlipidemia on low fat diet <br/>Hypothyroidism controlledGERD controlledChronic pain manage by PM <br/>BPH controlled, manage by Urologist [REDACTED]; f/up every six months; Patient was Dx with Hypospadia and recommended surgery, but pt is undecided to have it.<br/>ED controlled<br/>Lumbago controlled<br/>Osteoarthritis controlled Anxiety controlled<br/><span class="content_span">Patient had labs done which are reviewed [REDACTED].</span>Patients medication have been reviewed and does not report any side effects<br/>Patients current medication were reviewed and Refills given as in chart., <br/>Patient does not complain of any shortness of breath or chest pain.<br/>. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General / Constitutional</span>: <br/>      Fatigue denies. Fever denies. Headache denies. Lightheadedness denies. Night sweats denies.   <br/>   <span class="Underline">Allergy / Immunology</span>: <br/>      Congestion denies. Cough denies.   <br/>   <span class="Underline">ENT</span>: <br/>      Decreased hearing denies. Decreased sense of smell denies. Difficulty in swallowing denies. Ear pain denies. Nasal congestion denies.   <br/>   <span class="Underline">Endocrine</span>: <br/>      Dizziness denies. Excessive sweating denies. Excessive thirst denies. Frequent urination denies. Heat intolerance denies.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Chest pain denies. Chest pain at rest denies. Claudication denies. Dizziness denies. Dyspnea on exertion denies.   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      Abdominal pain denies. Blood in stool denies. Change in bowel habits denies. Constipation denies. Decreased appetite denies. Diarrhea denies.   <br/>   <span class="Underline">Hematology</span>: <br/>      Easy bleeding denies. Bleeding problems denies. Fever denies.   <br/>   <span class="Underline">Genitourinary</span>: <br/>      Blood in the urine denies. Difficulty urinating denies. Frequent urination denies. Loss of urine with cough or laughter denies. Painful urination denies.   <br/>   <span class="Underline">Musculoskeletal</span>: <br/>      Back pain denies. Back problems denies. Joint stiffness denies. Leg cramps denies. Muscle aches denies.   <br/>   <span class="Underline">Peripheral Vascular</span>: <br/>      Absent pulses in feet denies. Absent pulses in hands denies. Blood clots in legs denies. Cold extremities denies. Pain / cramping in legs after exertion denies. Painful extremities denies.   <br/>   <span class="Underline">Skin</span>: <br/>      Changing moles denies. Discoloration denies. Dry skin denies. Hair changes denies. Itching denies.   <br/>   <span class="Underline">Neurologic</span>: <br/>      Balance difficulty denies. Difficulty speaking denies. Dizziness denies. Fainting denies. Gait abnormality denies. Headache denies.   <br/>   <span class="Underline">Psychiatric</span>: <br/>      Depressed mood denies. Difficulty sleeping denies. Loss of appetite denies. Mood disorder denies. Stressors denies.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> Herniated disc 2000Distal Bicep Tendon Alograft Umbilical hernia Hernia </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> No Hospitalization History.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father: deceased,  diagnosed with Other malignant neoplasm without specification of site. Mother: deceased. [REDACTED] brother(s)  - healthy. 2 daughter(s)  - healthy. . </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Migrated Social History:</span> <br/>       Drugs/Alcohol: (Alcohol Screen):Did you have a drink containing alcohol in the past year?: Yes, How often did you have a drink containing alcohol in the past year?: 2 to 4 times a month (2 points), How many drinks did you have on a typical day when you were drinking in the past year?: 1 or 2 drinks (0 point), How often did you have 6 or more drinks on one occasion in the past year?: Never (0 point), Points: 2, Interpretation: Negative. <br/>      Miscellaneous: (Caffeine:):yes frequency:, 1-2 cups per day(Exercise:):yes 2-3 times per week(Living with:):alone(Marital status:):single(Working):Disabled. <br/>      Tobacco Use: (Tobacco Use/Smoking):Are you a: nonsmoker. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingAtorvastatin Calcium 20 MG Tablet 1 tablet Orally Once a Night Diclofenac Sodium 3 % Gel 1 application 1-2 grams Externally Twice a day Famotidine 20 MG Tablet TAKE 1 TABLET TWICE DAILY   Levothyroxine Sodium 50 MCG Tablet 1 tablet in the morning on an empty stomach Orally Once a day Meloxicam 15 MG Tablet 1 tablet Orally Twice a day oxyCODONE HCl 15 MG Tablet 1 capsule as needed Orally Q6hrs PRN , Notes to Pharmacist: PMTadalafil 2.5 MG Tablet 1 tablet Orally Once a day Tamsulosin HCl   1 capsule Orally Once a day Taking Atorvastatin Calcium 20 MG Tablet 1 tablet Orally Once a Night Taking Diclofenac Sodium 3 % Gel 1 application 1-2 grams Externally Twice a day Taking Famotidine 20 MG Tablet TAKE 1 TABLET TWICE DAILY   Taking Levothyroxine Sodium 50 MCG Tablet 1 tablet in the morning on an empty stomach Orally Once a day Taking Meloxicam 15 MG Tablet 1 tablet Orally Twice a day Taking oxyCODONE HCl 15 MG Tablet 1 capsule as needed Orally Q6hrs PRN , Notes to Pharmacist: PMTaking Tadalafil 2.5 MG Tablet 1 tablet Orally Once a day Taking Tamsulosin HCl   1 capsule Orally Once a day Not-TakingFamotidine 40 MG Tablet TAKE 1 TABLET ONE TIME DAILY AT BEDTIME AS NEEDED   Neomycin-Polymyxin-HC 1 % Solution 4 drops into affected ear Otic every 8 hrs as needed Medication List reviewed and reconciled with the patientNot-Taking Famotidine 40 MG Tablet TAKE 1 TABLET ONE TIME DAILY AT BEDTIME AS NEEDED   Not-Taking Neomycin-Polymyxin-HC 1 % Solution 4 drops into affected ear Otic every 8 hrs as needed Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.no[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Ht: 71 in, Wt: <span class="bold">212</span> lbs, Wt-kg: 96.16 kg, BMI: <span class="bold">29.56</span> Index, BP: <span class="bold">113/68</span> mm Hg, HR: <span class="bold">48</span> /min, Temp: <span class="bold">97.2</span> F, RR: <span class="bold">16</span> /min, Oxygen sat %: <span class="bold">96</span> %, Body Surface Area: 2.19, Ht-cm: 180.34 cm.<br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><span class="bold">   Past Orders:</span></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:CBC With Differential/Platelet-005009</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left"/><td align="left">09:24 AM</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">WBC</td><td align="left">6.1<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">5.9<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">5.8<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">6.0<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">NR<br/></td></tr><tr><td align="left">RBC</td><td align="left">4.48<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td align="left">4.55<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td align="left">4.88<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td align="left">4.45<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Hemoglobin</td><td align="left">13.8<br/>(Ref Range: 13.0-17.7 g/dL)</td><td align="left">13.8<br/>(Ref Range: 13.0-17.7 g/dL)</td><td align="left">14.6<br/>(Ref Range: 13.0-17.7 g/dL)</td><td align="left">13.9<br/>(Ref Range: 13.0-17.7 g/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Hematocrit</td><td align="left">41.2<br/>(Ref Range: 37.5-51.0 %)</td><td align="left">41.6<br/>(Ref Range: 37.5-51.0 %)</td><td align="left">44.3<br/>(Ref Range: 37.5-51.0 %)</td><td align="left">40.8<br/>(Ref Range: 37.5-51.0 %)</td><td align="left">NR<br/></td></tr><tr><td align="left">MCV</td><td align="left">92<br/>(Ref Range: 79-97 fL)</td><td align="left">91<br/>(Ref Range: 79-97 fL)</td><td align="left">91<br/>(Ref Range: 79-97 fL)</td><td align="left">92<br/>(Ref Range: 79-97 fL)</td><td align="left">NR<br/></td></tr><tr><td align="left">MCH</td><td align="left">30.8<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">30.3<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">29.9<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">31.2<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">NR<br/></td></tr><tr><td align="left">MCHC</td><td align="left">33.5<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">33.2<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">33.0<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">34.1<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">RDW</td><td align="left">13.1<br/>(Ref Range: 11.6-15.4 %)</td><td align="left">13.0<br/>(Ref Range: 11.6-15.4 %)</td><td align="left">13.3<br/>(Ref Range: 11.6-15.4 %)</td><td align="left">13.3<br/>(Ref Range: 11.6-15.4 %)</td><td align="left">NR<br/></td></tr><tr><td align="left">Platelets</td><td align="left">187<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">168<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">172<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">167<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Neutrophils</td><td align="left">65<br/>(Ref Range: Not Estab. %)</td><td align="left">64<br/>(Ref Range: Not Estab. %)</td><td align="left">69<br/>(Ref Range: Not Estab. %)</td><td align="left">65<br/>(Ref Range: Not Estab. %)</td><td align="left">NR<br/></td></tr><tr><td align="left">Lymphs</td><td align="left">27<br/>(Ref Range: Not Estab. %)</td><td align="left">26<br/>(Ref Range: Not Estab. %)</td><td align="left">22<br/>(Ref Range: Not Estab. %)</td><td align="left">26<br/>(Ref Range: Not Estab. %)</td><td align="left">NR<br/></td></tr><tr><td align="left">Monocytes</td><td align="left">7<br/>(Ref Range: Not Estab. %)</td><td align="left">8<br/>(Ref Range: Not Estab. %)</td><td align="left">7<br/>(Ref Range: Not Estab. %)</td><td align="left">7<br/>(Ref Range: Not Estab. %)</td><td align="left">NR<br/></td></tr><tr><td align="left">Eos</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">2<br/>(Ref Range: Not Estab. %)</td><td align="left">2<br/>(Ref Range: Not Estab. %)</td><td align="left">2<br/>(Ref Range: Not Estab. %)</td><td align="left">NR<br/></td></tr><tr><td align="left">Basos</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">NR<br/></td></tr><tr><td align="left">Neutrophils (Absolute)</td><td align="left">3.9<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">3.7<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">4.0<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">3.9<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Lymphs (Absolute)</td><td align="left">1.7<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">1.5<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">1.3<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">1.6<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Monocytes(Absolute)</td><td align="left">0.4<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.4<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.4<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.4<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Eos (Absolute)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Baso (Absolute)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Immature Granulocytes</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">NR<br/></td></tr><tr><td align="left">Immature Grans (Abs)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Notes:</td><td align="left"/><td align="left">[REDACTED] [REDACTED] 12:14:15 PM EDT &gt;reviewed</td><td align="left">[REDACTED], Jobse [REDACTED] 01:43:41 PM &gt;reviewed</td><td align="left">[REDACTED], Jobse [REDACTED] 03:55:56 AM &gt;reviewed</td><td align="left"/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:Testosterone, Free+Total LC/MS-070195</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Testosterone, Total, LC/MS</td><td class="bold" align="left">250.1    L<br/>(Ref Range: 264.0-916.0 ng/dL)</td><td class="bold" align="left">188.7    L<br/>(Ref Range: 264.0-916.0 ng/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Free Testosterone(Direct)</td><td class="bold" align="left">3.8    L<br/>(Ref Range: 6.6-18.1 pg/mL)</td><td class="bold" align="left">3.6    L<br/>(Ref Range: 6.6-18.1 pg/mL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Notes:</td><td align="left"/><td align="left">[REDACTED], Jobse [REDACTED] 03:55:56 AM &gt;reviewed</td><td align="left"/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:PSA Total (Reflex To Free)-480772</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left"/><td align="left">09:24 AM</td></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Prostate Specific Ag</td><td align="left">0.8<br/>(Ref Range: 0.0-4.0 ng/mL)</td><td align="left">0.9<br/>(Ref Range: 0.0-4.0 ng/mL)</td></tr><tr><td align="left">Notes:</td><td align="left"/><td align="left">[REDACTED] [REDACTED] 12:14:15 PM EDT &gt;reviewed</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:CMP14+eGFR-334943</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Collection Time</td><td align="left"/><td align="left">09:24 AM</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td><td align="left">[REDACTED]</td></tr><tr><td align="left">Glucose</td><td align="left">86<br/>(Ref Range: 70-99 mg/dL)</td><td align="left">95<br/>(Ref Range: 70-99 mg/dL)</td><td align="left">86<br/>(Ref Range: 70-99 mg/dL)</td><td align="left">83<br/>(Ref Range: 70-99 mg/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">BUN</td><td class="bold" align="left">31    H<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">27<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">25<br/>(Ref Range: 8-27 mg/dL)</td><td class="bold" align="left">34    H<br/>(Ref Range: 8-27 mg/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Creatinine</td><td align="left">0.97<br/>(Ref Range: 0.76-1.27 mg/dL)</td><td align="left">0.84<br/>(Ref Range: 0.76-1.27 mg/dL)</td><td align="left">0.97<br/>(Ref Range: 0.76-1.27 mg/dL)</td><td align="left">0.97<br/>(Ref Range: 0.76-1.27 mg/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">eGFR</td><td align="left">86<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td align="left">96<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td align="left">86<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td align="left">87<br/>(Ref Range: &gt;59 mL/min/1.73)</td><td align="left">NR<br/></td></tr><tr><td align="left">BUN/Creatinine Ratio</td><td class="bold" align="left">32    H<br/>(Ref Range: 10-24)</td><td class="bold" align="left">32    H<br/>(Ref Range: 10-24)</td><td class="bold" align="left">26    H<br/>(Ref Range: 10-24)</td><td class="bold" align="left">35    H<br/>(Ref Range: 10-24)</td><td align="left">NR<br/></td></tr><tr><td align="left">Sodium</td><td align="left">138<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">141<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">140<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">141<br/>(Ref Range: 134-144 mmol/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">Potassium</td><td align="left">4.6<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">4.6<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">4.6<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">4.4<br/>(Ref Range: 3.5-5.2 mmol/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">Chloride</td><td align="left">103<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">105<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">103<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">104<br/>(Ref Range: 96-106 mmol/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">Carbon Dioxide, Total</td><td align="left">24<br/>(Ref Range: 20-29 mmol/L)</td><td align="left">22<br/>(Ref Range: 20-29 mmol/L)</td><td class="bold" align="left">19    L<br/>(Ref Range: 20-29 mmol/L)</td><td align="left">23<br/>(Ref Range: 20-29 mmol/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">Calcium</td><td align="left">8.9<br/>(Ref Range: 8.6-10.2 mg/dL)</td><td align="left">8.8<br/>(Ref Range: 8.6-10.2 mg/dL)</td><td align="left">9.1<br/>(Ref Range: 8.6-10.2 mg/dL)</td><td align="left">9.2<br/>(Ref Range: 8.6-10.2 mg/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Protein, Total</td><td align="left">6.0<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">6.0<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">6.8<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">6.3<br/>(Ref Range: 6.0-8.5 g/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Albumin</td><td align="left">4.0<br/>(Ref Range: 3.9-4.9 g/dL)</td><td align="left">4.1<br/>(Ref Range: 3.9-4.9 g/dL)</td><td align="left">4.5<br/>(Ref Range: 3.9-4.9 g/dL)</td><td align="left">4.3<br/>(Ref Range: 3.9-4.9 g/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Globulin, Total</td><td align="left">2.0<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">1.9<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">2.3<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">2.0<br/>(Ref Range: 1.5-4.5 g/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">A/G Ratio</td><td align="left">NR<br/></td><td align="left">2.2<br/>(Ref Range: 1.2-2.2)</td><td align="left">2.0<br/>(Ref Range: 1.2-2.2)</td><td align="left">2.2<br/>(Ref Range: 1.2-2.2)</td><td align="left">NR<br/></td></tr><tr><td align="left">Bilirubin, Total</td><td align="left">0.4<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">0.4<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">0.5<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">0.5<br/>(Ref Range: 0.0-1.2 mg/dL)</td><td align="left">NR<br/></td></tr><tr><td align="left">Alkaline Phosphatase</td><td align="left">61<br/>(Ref Range: 44-121 IU/L)</td><td align="left">57<br/>(Ref Range: 44-121 IU/L)</td><td align="left">59<br/>(Ref Range: 44-121 IU/L)</td><td align="left">61<br/>(Ref Range: 44-121 IU/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">AST (SGOT)</td><td align="left">20<br/>(Ref Range: 0-40 IU/L)</td><td align="left">21<br/>(Ref Range: 0-40 IU/L)</td><td align="left">24<br/>(Ref Range: 0-40 IU/L)</td><td align="left">19<br/>(Ref Range: 0-40 IU/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">ALT (SGPT)</td><td align="left">19<br/>(Ref Range: 0-44 IU/L)</td><td align="left">19<br/>(Ref Range: 0-44 IU/L)</td><td align="left">22<br/>(Ref Range: 0-44 IU/L)</td><td align="left">20<br/>(Ref Range: 0-44 IU/L)</td><td align="left">NR<br/></td></tr><tr><td align="left">Notes:</td><td align="left"/><td align="left">[REDACTED] [REDACTED] 12:14:15 PM EDT &gt;reviewed</td><td align="left">[REDACTED], Jobse [REDACTED] 01:43:41 PM &gt;reviewed</td><td align="left">[REDACTED], Jobse [REDACTED] 03:55:56 AM &gt;reviewed</td><td align="left"/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: well-appearing, well-developed, no acute distress , alert, and oriented . <br/>      Neck / thyroid: no lymphadenopathy, no thyromegaly, <span class="content_span">neck is supple, </span>. <br/>      Heart: regular rhythm, S1S2 normal, no S3 S4, regular rate and rhythm no clicks or rubs. <br/>      Chest: symmetric without any chest wall tenderness. <br/>      Lungs: nonlabored respirations, lungs are clear bilaterally without rales or rhonchi. <br/>      Abdomen: soft, non tender, not distended, soft with good bowel sounds, no masses . <br/>      Neurologic:  A &amp;O x 3, no new focal deficits, non-focal exam.. <br/>      Back: no spinal deformity or tenderness, no CVA tenderness. <br/>      Musculoskeletal: no new joint swellings or deformities , no swelling, redness, or warmth . <br/>      Skin: skin is warm and dry, with no rashes, good skin turgor and normal hair distribution. <br/>      Head: normocephalic, atraumatic. <br/>      Eyes: pupils equal, round, reactive to light and accommodation. <br/>      Ears: normal , auditory canal clear. <br/>      Nose: nares patent , no lesions. <br/>      Oral cavity: normal , mucosa moist. <br/>      Throat: no erythema , no exudate , . <br/>      Extremities: normal extremity with no clubbing, cyanosis or edema. <br/>      Peripheral pulses: normal 2+ arterial pulses. <br/>      Cardiovascular S1 and S2 regular, no gallop.. <br/>      Respiratory Clear to auscultation bilaterally. bilateral breath sounds present. <br/>      Gastrointestinal soft, non-tender/non-distended, no guarding or rigidity, bowel sounds present..    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Acquired hypothyroidism - E03.9 (Primary)   2. Mixed hyperlipidemia - E78.2   3. Other osteoarthritis involving multiple joints - M15.8   4. Gastroesophageal reflux disease without esophagitis - K21.9   5. Anxiety - F41.9   6. Low testosterone in male - R79.89   7. Other chronic pain - G89.29   8. Hesitancy of micturition - R39.11   9. Drug-induced erectile dysfunction - N52.2   10. Opioid dependence in controlled environment - F11.20   11. Sleep apnea, unspecified - G47.30   12. Hiatal hernia - K44.9   <content><span class="bold">Notes : </span>Bayarea Advance Gastroeneterology Care [REDACTED] notes dated [REDACTED]</content>   13. Opioid use, unspecified with opioid-induced sexual dysfunction - F11.981   14. Seasonal allergies - J30.2   15. Hepatic cyst - K76.89   16. BPH (BENIGN PROSTATIC HYPERPLASIA) - N40.0   17. BMI 31.0-31.9,adult - Z68.31   18. PENILE HYPOSPADIAS - Q54.1   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Acquired hypothyroidism</span> <br/>Continue Levothyroxine Sodium Tablet, 50 MCG, 1 tablet in the morning on an empty stomach, Orally, Once a day, 90 days, 90 Tablet, Refills 1.  <br/>Notes: Continue current treatment  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Mixed hyperlipidemia</span> <br/>Continue Atorvastatin Calcium Tablet, 20 MG, 1 tablet, Orally, Once a Night, 90 days, 90, Refills 1.  <br/>Notes: Continue current therapy, low fat diet  </td></tr><tr><td/></tr><tr><td><span class="bold">3. Other osteoarthritis involving multiple joints</span> <br/>Continue Meloxicam Tablet, 15 MG, 1 tablet, Orally, Twice a day; Continue oxyCODONE HCl Tablet, 15 MG, 1 capsule as needed, Orally, Q6hrs PRN, Notes to Pharmacist: PM; Continue Diclofenac Sodium Gel, 3 %, 1 application 1-2 grams, Externally, Twice a day, 30 days, 1, Refills 1.  <br/>Notes: Continue current treatment  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Gastroesophageal reflux disease without esophagitis</span> <br/>Continue Famotidine Tablet, 20 MG, 1 tablet at bedtime as needed, Orally, [REDACTED] a day, 90 days, 180 Tablet, Refills 0.  <br/>Notes: Avoid irritant foods  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Anxiety</span> <br/>Notes: Continue current treatment  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Low testosterone in male</span> <br/>Notes: Lab reviewed with pt; refused Rx Tx  </td></tr><tr><td/></tr><tr><td><span class="bold">7. Other chronic pain</span> <br/>Notes: PRN TYLENOL for Pain  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Hesitancy of micturition</span> <br/>Notes: monitor for changes  </td></tr><tr><td/></tr><tr><td><span class="bold">9. Drug-induced erectile dysfunction</span> <br/>Notes: take medication as indicated by Urologist  </td></tr><tr><td/></tr><tr><td><span class="bold">10. Opioid dependence in controlled environment</span> <br/>Notes: <content><content><br/>Patient was informed of non-opioid alternativesthat are available, which may include non-opioid medicinal drugs,interventional procedures, acupuncture, chiropractic treatment, massage therapyor other appropriate treatment.</content></content>  </td></tr><tr><td/></tr><tr><td><span class="bold">11. Sleep apnea, unspecified</span> <br/>Notes: monitor for changes  </td></tr><tr><td/></tr><tr><td><span class="bold">12. Hiatal hernia</span> <br/>Notes: monitor for changes  </td></tr><tr><td/></tr><tr><td><span class="bold">13. Opioid use, unspecified with opioid-induced sexual dysfunction</span> <br/>Notes: 1) Drug has been taken for lager amount or over longer period than was intended <br/>2) Persistent desire or unsuccessful efforts to cut down or control use <br/>3) Craving or strong desire or urge to use the drug <br/>4) continued use despite knowledge of having a persistent or recurrent physical or psychological problem that is likely caused or exacerbated by the drug.  </td></tr><tr><td/></tr><tr><td><span class="bold">14. Seasonal allergies</span> <br/>Notes: - Stable, will keep monitoring  </td></tr><tr><td/></tr><tr><td><span class="bold">15. Hepatic cyst</span> <br/>Notes: - Stable, will keep monitoring  </td></tr><tr><td/></tr><tr><td><span class="bold">16. BPH (BENIGN PROSTATIC HYPERPLASIA)</span> <br/>Notes: - Stable, will keep monitoring          <br/> Referral To:[REDACTED]  Urology<br/>              Reason:New patient<br/></td></tr><tr><td/></tr><tr><td><span class="bold">17. BMI 31.0-31.9,adult</span> <br/>Notes: Discussed diet modifications and increase in physical activity to obtain or maintain goal BMI  </td></tr><tr><td/></tr><tr><td><span class="bold">18. PENILE HYPOSPADIAS</span> <br/>Notes: Urology follow up  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> G8417 BMI &gt;=30 CALCUATE W/FOLLOWUP3074F SYST BP LT 130 MM HG3078F DIAST BP &lt; 80 MM HGG8427 DOC MEDS VERIFIED W/PT OR RE1170F FXNL STATUS ASSESSED1126F AMNT PAIN NOTED NONE PRSNT1158F ADVNC CARE PLAN TLK DOCD1159F MED LIST DOCD IN RCRD1160F RVW MEDS BY RX/DR IN RCRD3288F FALL RISK ASSESSMENT DOCD3017F COLORECTAL CA SCREEN DOC REV4013F STATIN THERAPY/CURRENTLY TKN</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Preventive Medicine:</span> <br/>  Your Annual Wellness Plan: <br/>       BMI, height, and weight: <br/>          My BMI, height, and weight were taken on: <span class="italics">[REDACTED] Educated on healthy diet and exercise; follow a healthy diet; increase fluids and walk at least 30 minutes a day for 5 days; wear comfortable walking shoes and walk at your own pace.</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 3 Months,on Regular Scheduled OV (Reason: Follow-up of chronic conditions)</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>G8417 BMI &gt;=30 CALCUATE W/FOLLOWUP. <br/>3074F SYST BP LT 130 MM HG. <br/>3078F DIAST BP &lt; 80 MM HG. <br/>G8427 DOC MEDS VERIFIED W/PT OR RE. <br/>1170F FXNL STATUS ASSESSED. <br/>1126F AMNT PAIN NOTED NONE PRSNT. <br/>1158F ADVNC CARE PLAN TLK DOCD. <br/>1159F MED LIST DOCD IN RCRD. <br/>1160F RVW MEDS BY RX/DR IN RCRD. <br/>3288F FALL RISK ASSESSMENT DOCD. <br/>3017F COLORECTAL CA SCREEN DOC REV. <br/>4013F STATIN THERAPY/CURRENTLY TKN. </td></tr></tbody></table></li></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED] , MD, ACN765  on [REDACTED] 01:33 AM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED], MD</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 01:03 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id12" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td>[REDACTED]</td><td>Patient is here for</td><td colspan="2"><p>Patient came in to the office [REDACTED] for EOV for labs and echo results with monitoring;  Hyperlipidemia on low fat diet  Hypothyroidism controlledGERD controlledChronic pain manage by PM  BPH controlled, manage by Urologist [REDACTED]; f/up every six months; Patient was Dx with Hypospadia and recommended surgery, but pt is undecided to have it. ED controlled Lumbago controlled Osteoarthritis controlled Anxiety controlled </p><p>Patient had labs done which are reviewed [REDACTED].</p><p>Patients medication have been reviewed and does not report any side effects Patients current medication were reviewed and Refills given as in chart.,  Patient does not complain of any shortness of breath or chest pain. </p></td></tr></tbody></table><br/><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="25">General Examination</td><td>General appearance:</td><td colspan="2">well-appearing, well-developed, no acute distress , alert, and oriented </td></tr><tr><td>Head:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>Eyes:</td><td colspan="2">pupils equal, round, reactive to light and accommodation</td></tr><tr><td>Ears:</td><td colspan="2">normal , auditory canal clear</td></tr><tr><td>Nose:</td><td colspan="2">nares patent , no lesions</td></tr><tr><td>Throat:</td><td colspan="2">no erythema , no exudate ,</td></tr><tr><td>Neck / thyroid:</td><td colspan="2">no lymphadenopathy, no thyromegaly, neck is supple, </td></tr><tr><td>Heart:</td><td colspan="2">regular rhythm, S1S2 normal, no S3 S4, regular rate and rhythm no clicks or rubs</td></tr><tr><td>Chest:</td><td colspan="2">symmetric without any chest wall tenderness</td></tr><tr><td>Lungs:</td><td colspan="2">nonlabored respirations, lungs are clear bilaterally without rales or rhonchi</td></tr><tr><td>Abdomen:</td><td colspan="2">soft, non tender, not distended, soft with good bowel sounds, no masses </td></tr><tr><td>Neurologic:</td><td colspan="2"> A &amp;O x 3, no new focal deficits, non-focal exam.</td></tr><tr><td>Skin:</td><td colspan="2">skin is warm and dry, with no rashes, good skin turgor and normal hair distribution</td></tr><tr><td>Extremities:</td><td colspan="2">normal extremity with no clubbing, cyanosis or edema</td></tr><tr><td>Peripheral pulses:</td><td colspan="2">normal 2+ arterial pulses</td></tr><tr><td>Back:</td><td colspan="2">no spinal deformity or tenderness, no CVA tenderness</td></tr><tr><td>Breasts:</td><td colspan="2"/></tr><tr><td>Musculoskeletal:</td><td colspan="2">no new joint swellings or deformities , no swelling, redness, or warmth</td></tr><tr><td>Oral cavity:</td><td colspan="2">normal , mucosa moist</td></tr><tr><td>HEENT</td><td colspan="2"/></tr><tr><td>Cardiovascular</td><td colspan="2">S1 and S2 regular, no gallop.</td></tr><tr><td>Respiratory</td><td colspan="2">Clear to auscultation bilaterally. bilateral breath sounds present</td></tr><tr><td>Gastrointestinal</td><td colspan="2">soft, non-tender/non-distended, no guarding or rigidity, bowel sounds present.</td></tr><tr><td>Neurological Exam</td><td colspan="2"/></tr><tr><td>Genitourinary</td><td colspan="2"/></tr></tbody></table><br/></li></ul></div><h3><a name="id13" href="#toc">Consultation Request Notes</a></h3><div><table width="100%" border="1"><tbody><tr><th>Referral Date</th><th>Referring Provider</th><th>Referred Provider</th><th>Notes</th></tr><tr ID="ConsultationNote1"><td>[REDACTED]</td><td>[REDACTED], Jobse</td><td>[REDACTED]</td><td>New patient</td></tr></tbody></table></div><br/><br/>
</body></html>